BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 2830044)

  • 1. Renal effects of atrial natriuretic factor during control of the renin-angiotensin system in anesthetized dogs.
    Seymour AA; Mazack EK
    Circ Res; 1988 Mar; 62(3):506-14. PubMed ID: 2830044
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of angiotensin converting enzyme inhibition and angiotensin II type 1 receptor antagonism on renal sodium and water handling and albuminuria during infusion of atrial natriuretic factor into healthy volunteers.
    Vervoort G; Hertenberg F; Wetzels JF; Smits P
    J Hypertens; 1998 Feb; 16(2):245-50. PubMed ID: 9535153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship of the renin-angiotensin system and systemic arterial pressure to sodium excretion during atrial natriuretic peptide infusion in men.
    Grandis DJ; Uretsky BF; Verbalis JG; Chong TK; Puschett JB
    Am J Hypertens; 1992 Nov; 5(11):793-9. PubMed ID: 1457079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardio-renal-endocrine dynamics during stepwise infusion of physiologic and pharmacologic concentrations of atrial natriuretic factor in the dog.
    Zimmerman RS; Schirger JA; Edwards BS; Schwab TR; Heublein DM; Burnett JC
    Circ Res; 1987 Jul; 61(1):63-9. PubMed ID: 2955951
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of atrial natriuretic factor on the vasoconstrictor actions of the renin-angiotensin system in conscious rats.
    Lappe RW; Todt JA; Wendt RL
    Circ Res; 1987 Jul; 61(1):134-40. PubMed ID: 3038365
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resistance to blockade by saralasin of effect of ACE inhibitors in conscious sodium-restricted dog.
    Zimmerman BG; Goering JL; Raich PC
    Am J Physiol; 1988 Nov; 255(5 Pt 2):F944-52. PubMed ID: 2847552
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renal and adrenal resistance against atrial natriuretic peptide in congestive heart failure: effect of angiotensin I-converting-enzyme inhibition.
    Wambach G; Schittenhelm U; Bönner G; Kaufmann W
    Cardiology; 1989; 76(6):418-27. PubMed ID: 2558792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natriuresis in conscious dogs caused by increased carotid [Na+] during angiotensin II and aldosterone blockade.
    Emmeluth C; Drummer C; Gerzer R; Bie P
    Acta Physiol Scand; 1994 Jul; 151(3):403-11. PubMed ID: 7976412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of auriculin (atrial natriuretic factor) on blood pressure, renal function, and the renin-aldosterone system in dogs.
    Maack T; Marion DN; Camargo MJ; Kleinert HD; Laragh JH; Vaughan ED; Atlas SA
    Am J Med; 1984 Dec; 77(6):1069-75. PubMed ID: 6239544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal mechanisms for suppression of renin secretion by atrial natriuretic factor.
    Villarreal D; Freeman RH; Davis JO; Verburg KM; Vari RC
    Hypertension; 1986 Jun; 8(6 Pt 2):II28-35. PubMed ID: 2941371
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human C-type natriuretic peptide: effects on the haemodynamic and endocrine responses to angiotensin II.
    Cargill RI; Struthers AD; Lipworth BJ
    Cardiovasc Res; 1995 Jan; 29(1):108-11. PubMed ID: 7895227
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atrial natriuretic factor modulates proximal glomerulotubular balance in anesthetized rats.
    Zhuo JL; Harris PJ; Skinner SL
    Hypertension; 1989 Dec; 14(6):666-73. PubMed ID: 2555304
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term hypotensive and renal effects of atrial natriuretic peptide.
    Granger JP; Opgenorth TJ; Salazar J; Romero JC; Burnett JC
    Hypertension; 1986 Jun; 8(6 Pt 2):II112-6. PubMed ID: 2941368
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal effects of urodilatin and atrial natriuretic peptide in volume expanded conscious dogs.
    Bestle MH; Bie P
    Acta Physiol Scand; 1993 Sep; 149(1):77-83. PubMed ID: 8237425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atrial natriuretic peptide in chronically hypertensive dogs.
    Seymour AA; Asaad MM; Sheldon JH; Smith PL; Rogers WL
    Hypertension; 1995 Oct; 26(4):634-41. PubMed ID: 7558224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systemic effects of angiotensin III in conscious dogs during acute double blockade of the renin-angiotensin-aldosterone-system.
    Gammelgaard I; Wamberg S; Bie P
    Acta Physiol (Oxf); 2006 Oct; 188(2):129-38. PubMed ID: 16948800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of synthetic rat and human atrial natriuretic factor in conscious dogs.
    Seymour AA; Smith SG; Mazack EK; Blaine EH
    Hypertension; 1986 Mar; 8(3):211-6. PubMed ID: 2936682
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative effects of atrial natriuretic peptide and brain natriuretic peptide on the aldosterone and pressor responses to angiotensin II in man.
    Cargill RI; Struthers AD; Lipworth BJ
    Clin Sci (Lond); 1995 Jan; 88(1):81-6. PubMed ID: 7705006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal effects of prolonged intrarenal infusions of angiotensin II and atrial natriuretic peptide in sheep.
    Fan L; Mukaddam-Daher S; Javeshghani D; Quillen E; Gutkowska J
    J Cardiovasc Pharmacol; 1999 Sep; 34(3):427-33. PubMed ID: 10471003
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of renal actions of urodilatin and atrial natriuretic peptide.
    Hildebrandt DA; Mizelle HL; Brands MW; Hall JE
    Am J Physiol; 1992 Mar; 262(3 Pt 2):R395-9. PubMed ID: 1313650
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.